EXAS
NASDAQ · Biotechnology
Exact Sciences Corp
$104.91
+0.99 (+0.95%)
Performance
1D
—
1W
—
1M
—
3M
+3.29%
6M
+95.84%
1Y
+129.71%
YTD
+3.12%
Open$104.93
Previous Close$103.92
Day High$104.98
Day Low$104.90
52W High$103.54
52W Low$38.81
Volume—
Avg Volume2.42M
Market Cap19.73B
P/E Ratio—
EPS$-5.32
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$102.19
Above
SMA 200
$69.24
Above
RSI (14)
74.6
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
29 analysts
Price Target
+24.6% upside
Current
$104.91
$104.91
Target
$130.71
$130.71
$80.73
$130.71 avg
$205.54
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.86B | 2.46B | 5.75B |
| Net Income | -1,066,070,480 | -827,052,350 | -895,146,132 |
| Profit Margin | -37.3% | -35.4% | -15.6% |
| EBITDA | -1,064,505,424 | -871,718,087 | -1,423,315,581 |
| Free Cash Flow | — | — | -873,819,141 |
| Rev Growth | +16.0% | +16.0% | -4.7% |
| Debt/Equity | 1.08 | 1.08 | 0.09 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |